Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 33, 2022 - Issue 5
Submit an article Journal homepage
92
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Letter to the editor submitted in response to ‘Should the presence of psoriatic arthritis change how we manage psoriasis?’

Matteo Megnaa Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico IICorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1803-2046
ORCID Icon,
Sonia Sofia Ocampo-Garzaa Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II;b Dermatology Department, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico
,
Gabriella Fabbrocinia Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II
&
Luca Potestioa Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II
Pages 2695-2696 | Received 25 Dec 2021, Accepted 28 Jan 2022, Published online: 12 Aug 2022

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Matteo Megna, Elisa Camela, Teresa Battista, Lucia Genco, Fabrizio Martora, Matteo Noto, Vincenzo Picone, Angelo Ruggiero, Giuseppe Monfrecola, Gabriella Fabbrocini & Luca Potestio. (2023) Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients. Expert Opinion on Drug Safety 22:1, pages 25-41.
Read now

Articles from other publishers (1)

Matteo Megna, Luca Potestio, Angelo Ruggiero, Elisa Camela & Gabriella Fabbrocini. (2022) Risankizumab treatment in psoriasis patients who failed anti‐IL17: A 52‐week real‐life study. Dermatologic Therapy 35:7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.